Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the ‘benzofuran’ compounds. A report from the United Kingdom National Poisons Information Service

Ashraf KamourNational Poisons Information Service, Newcastle Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Wolfson Unit, Newcastle upon Tyne, UK

David JamesNational Poisons Information Service, Newcastle Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Wolfson Unit, Newcastle upon Tyne, UK

David J. LuptonNational Poisons Information Service, Edinburgh Unit, Royal Infirmary of Edinburgh, Edinburgh, UK

Gillian CooperNational Poisons Information Service, Cardiff Unit, University Hospital Llandough, Penarth, Vale of Glamorgan, UK

Micheal EddlestonPharmacology, Toxicology and Therapeutics, University/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK

Allister ValeNational Poisons Information Service, Birmingham Unit, City Hospital, Dudley Road, Birmingham, UK

John P. ThompsonNational Poisons Information Service, Cardiff Unit, University Hospital Llandough, Penarth, Vale of Glamorgan, UK

Ruben ThanacoodyNational Poisons Information Service, Newcastle Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Wolfson Unit, Newcastle upon Tyne, UK;Medical Toxicology Centre, Institute of Cellular Medicine, Wolfson Building, Newcastle University, Newcastle upon Tyne, UK

Simon L. HillNational Poisons Information Service, Newcastle Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Wolfson Unit, Newcastle upon Tyne, UK;Medical Toxicology Centre, Institute of Cellular Medicine, Wolfson Building, Newcastle University, Newcastle upon Tyne, UK

Simon H. L. ThomasNational Poisons Information Service, Newcastle Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Wolfson Unit, Newcastle upon Tyne, UK;Medical Toxicology Centre, Institute of Cellular Medicine, Wolfson Building, Newcastle University, Newcastle upon Tyne, UKCorrespondence[email protected]

show all

Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the ‘benzofuran’ compounds. A report from the United Kingdom National Poisons Information Service

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the ‘benzofuran’ compounds. A report from the United Kingdom National Poisons Information Service

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date